Mark Layton Email
Vice President in Development and MDL Otilimab @ GSK
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
Mark Layton Location
- London, GB
Mark Layton Work
- Vice President in Development and MDL Otilimab @ (April 2015 - Present)
- Head of Discovery Medicine, Immunoinflammation Tau @ (September 2012 - April 2015)
- Medical Science Director @ (November 2006 - August 2012)
- Fellow @ FPM (January 2008 - January 2012)
- Clinical Expert @ Celltech (January 2003 - January 2005)
- Global Clinical Leader @ (January 2000 - January 2003)
- New Business Development Medical Manager @ (January 1999 - January 2000)
- Medical Affairs Manager @ (January 1998 - January 1999)
- NHS Positions, Clinical and Research @ (January 1989 - January 1998)
Mark Layton Education
- University of Nottingham
Bachelor of Science (Medicine)
1984-1989
Mark Layton Skills
- Clinical Research
- Clinical Trials
- Medical Affairs
- Clinical Development
- Drug Development
- Pharmaceutical Industry
- Medicine
- Infectious Diseases
- Oncology
- Life Sciences
- Pharmacovigilance
- Medical Writing
- Biotechnology
- CRO
- GCP
- R&d
- CRO Management
- Good Clinical Practice Gcp
- Good Clinical Practice
Mark Layton Summary
- Mark Layton, based in London, GB, is currently a Vice President in Development and MDL Otilimab at GSK. Mark Layton brings experience from previous roles at GSK, Astrazeneca, FPM and Celltech. Mark Layton holds a 1984 - 1989 Bachelor of Science in Medicine @ University of Nottingham. With a robust skill set that includes Clinical Research, Clinical Trials, Medical Affairs, Clinical Development, Drug Development and more. Mark Layton has 1 emails on RocketReach.
Looking for a different Mark Layton?
Find contact details for 700 million professionals.
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co